var data={"title":"Betaine (anhydrous, not equivalent to betaine hydrochloride): Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Betaine (anhydrous, not equivalent to betaine hydrochloride): Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/5731?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-patient-drug-information\" class=\"drug drug_patient\">see &quot;Betaine (anhydrous, not equivalent to betaine hydrochloride): Patient drug information&quot;</a> and <a href=\"topic.htm?path=betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Betaine (anhydrous, not equivalent to betaine hydrochloride): Pediatric drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140590\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Cystadane</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140591\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Cystadane</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140600\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Homocystinuria, Treatment Agent</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140592\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Homocystinuria:</b> Oral: 3 g twice daily. Dosages of up to 20 g/day have been necessary to control homocysteine levels in some patients. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Note:</b> Dosage in all patients can be gradually increased until plasma total homocysteine is undetectable or present only in small amounts. One in vitro study indicated minimal benefit from exceeding a twice daily dosing schedule and a 150 mg/kg/day dosage.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140596\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Betaine (anhydrous, not equivalent to betaine hydrochloride): Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Homocystinuria:</b> Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">\n      <i>Infants and Children &lt;3 years:</i> Initial dose: 100 mg/kg/day in 2 divided doses; increase weekly by 50 mg/kg increments, as needed</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">\n      <i>Children &ge;3 years and Adolescents:</i> Refer to adult dosing. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Note:</b> Dosage in all patients can be gradually increased until plasma total homocysteine is undetectable or present only in small amounts. One in vitro study  indicated minimal benefit from exceeding a twice daily dosing schedule and a 150 mg/kg/day dosage.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140593\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25246619\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25246620\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140580\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Powder, Oral, as anhydrous: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cystadane: 1 g/scoop (180 g)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140570\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">No</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F11239625\" class=\"block accres drugH1Div\"><span class=\"drugH1\">Prescribing and Access Restrictions</span>\n    <p style=\"text-indent:0em;display:inline\">Cystadane may be obtained by contacting AnovoRx at wholesale@anovorx.com.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140582\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">For oral administration. Administer without regard to food immediately after reconstitution.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140581\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Homocystinuria:</b> Treatment of homocystinuria  including deficiencies or defects in cystathionine beta-synthase (CBS), 5,10-methylene tetrahydrofolate reductase (MTHFR), and cobalamin cofactor metabolism (CBL).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140604\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Betaine anhydrous may be confused with betaine hydrochloride (a nutritional supplement)</p>\n        <p style=\"text-indent:-2em;margin-left:4em;\">Betaine may be confused with Betadine</p>\n        <p style=\"text-indent:-2em;margin-left:4em;\">Cystadane may be confused with cysteamine, cysteine</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140575\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Frequency not defined.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gastrointestinal: Diarrhea, dysgeusia, gastrointestinal distress, nausea</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">&lt;1%, postmarketing, and/or case reports: Abnormal skin odor, agitation, alopecia, anorexia, cerebral edema (associated with hypermethioninemia), dental disease, depression, glossitis, irritability, personality disorder, sleep disorder, urinary incontinence, urticaria, vomiting</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140584\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">There are no contraindications listed in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2989268\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Special populations:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Cystathionine beta-synthase (CBS) deficiency: Use caution in patients with CBS deficiency; treatment with betaine may cause large increases of plasma methionine concentrations which may cause cerebral edema.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <i>\n        <b>&#65279;Dosage form specific issues: </b></i></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: Betaine anhydrous, a prescription medication indicated for the treatment of homocystinuria and betaine hydrochloride, a nutritional supplement, are not to be used interchangeably (ISMP 2016).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13298857\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6218393\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=8598&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:0em;display:inline\">There are no known significant interactions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140577\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140587\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Animal reproduction studies have not been conducted.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F3342810\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">It is not known if betaine is excreted in breast milk. According to the manufacturer, use in nursing women only if clearly needed.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F3342811\" class=\"block dic drugH1Div\"><span class=\"drugH1\">Dietary Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">May be mixed with water, juice, milk, formula, or with food. Betaine is a metabolite of choline and is present in small amounts in foods such as beets, spinach, cereals, and seafood.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2989272\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;\">Total plasma homocysteine levels to determine therapeutic response. In patients with elevated plasma methionine (eg, CBS deficiency), monitor plasma methionine (maintain &lt;1000 micromol/L).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F3343058\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Betaine is an endogenous metabolite of choline. Betaine acts as a methyl group donor in the remethylation of homocysteine to methionine. Homocystinuria is an inborn error of metabolism in which elevated plasma homocysteine levels can lead to mental retardation, ocular abnormalities, osteoporosis, premature atherosclerosis and thromboembolic disease. Remethylation is one of the two divergent pathways in the metabolism of homocysteine. The second pathway involves transulfuration of homocysteine to produce cysteine.  A number of enzymes and cofactors are also involved in these pathways. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6038539\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Cystadan (AU, IL);</li>\n      <li>Cystadane (BB, CZ, DK, EE, HU, IS, JP, KR, LT, LV, MT, NO, PL, SE, SI, SK);</li>\n      <li>Reqmed (JP)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Acute Care ISMP Medication Safety Alert! http://www.ismp.org/newsletters/acutecare/issue.aspx?id=1139. Published December 1, 2016. Accessed March 8, 2018.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Burns SP, Iles RA, Ryalls M, et al. Methylgenesis from betaine in cystathionine-beta-synthase deficiency.<i>Biochem Soc Trans</i>. 1993;21:455S.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-drug-information/abstract-text/7510653/pubmed\" target=\"_blank\" id=\"7510653\">7510653</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cystadane (betaine anhydrous) [prescribing information]. Memphis, TN: AnovoRx Distribution, LLC; April 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Devlin AM, Hajipour L, Gholkar A, &ldquo;Cerebral Edema Associated With Betaine Treatment in Classical Homocystinuria,&rdquo; <i>J Pediatr</i>, 2001,144(4):545-8.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-drug-information/abstract-text/15069409/pubmed\" target=\"_blank\" id=\"15069409\">15069409</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kishi T, Kawamura I, Harada Y, et al, &ldquo;Effect of Betaine on S-Adenosylmethionine Levels in the Cerebrospinal Fluid in a Patient With Methylenetetrahydrofolate Reductase Deficiency and Peripheral Neuropathy,&rdquo; <i>J Inherit Metab Dis</i>, 1994, 17:560-5.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-drug-information/abstract-text/7837762/pubmed\" target=\"_blank\" id=\"7837762\">7837762</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lawson-Yuen A and Levy, HL, &ldquo;The Use of Betaine in the Treatment of Elevated Homocysteine,&rdquo; <i>Mol Genet Metab</i>, 2006, 88(3):201-7.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-drug-information/abstract-text/16545978/pubmed\" target=\"_blank\" id=\"16545978\">16545978</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Matthews A, Johnson TN, Rostami-Hodjegan A, et al. An indirect response model of homocysteine suppression by betaine: optimising the dosage regimen of betaine in homocystinuria. <i>Br J Clin Pharmacol</i>. 2002;54(2):140-146.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-drug-information/abstract-text/12207633/pubmed\" target=\"_blank\" id=\"12207633\">12207633</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Smolin LA, Benevenga NJ, and Berlow S, &ldquo;The Use of Betaine for the Treatment of Homocystinuria,&rdquo; <i>J Pediatr</i>, 1981, 99:467-72.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-drug-information/abstract-text/7264811/pubmed\" target=\"_blank\" id=\"7264811\">7264811</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 8598 Version 79.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F140590\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F140591\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F140600\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F140592\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F140596\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F140593\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F25246619\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F25246620\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F140580\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F140570\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Prescribing and Access Restrictions\" href=\"#F11239625\" class=\"outlineLink\">Prescribing and Access Restrictions</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F140582\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F140581\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F140604\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F140575\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F140584\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F2989268\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13298857\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F6218393\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F140577\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F140587\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F3342810\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Dietary Considerations\" href=\"#F3342811\" class=\"outlineLink\">Dietary Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F2989272\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F3343058\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F6038539\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/8598|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-patient-drug-information\" class=\"drug drug_patient\">Betaine (anhydrous, not equivalent to betaine hydrochloride): Patient drug information</a></li><li><a href=\"topic.htm?path=betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-pediatric-drug-information\" class=\"drug drug_pediatric\">Betaine (anhydrous, not equivalent to betaine hydrochloride): Pediatric drug information</a></li></ul></div></div>","javascript":null}